Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R4KQ
|
|||
| Former ID |
DNC010949
|
|||
| Drug Name |
4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide
|
|||
| Synonyms |
CHEMBL1163382; 4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H12N4O2S
|
|||
| Canonical SMILES |
CC1CC=NN1C2=C(C=NC=C2)S(=O)(=O)N
|
|||
| InChI |
1S/C9H12N4O2S/c1-7-2-5-12-13(7)8-3-4-11-6-9(8)16(10,14)15/h3-7H,2H2,1H3,(H2,10,14,15)
|
|||
| InChIKey |
LMKCKKHGIIIBOX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associa... Eur J Med Chem. 2010 Jun;45(6):2396-404. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.